New program brings cancer survivors together


A new program begins this month that is designed to offer cancer patients a way to learn about the disease and to meet other survivors.

The Survivors' Symposium begins Wednesday, Jan. 21, at 6:30 p.m. in the conference room at the Mary Washington Home Health office in Massaponax.

Dr. Sudeep Menachery, a Fredericksburg hematologist and oncologist, will speak on the long-term effects of chemotherapy. The program is free and open to the public.

The program is sponsored by the Oncology Resources Services division at Mary Washington Hospital and its cancer-navigator program.

Organizers met with cancer survivors in October to measure their interest in a program and to see which topics might interest them.

They hope to sponsor quarterly sessions that differ from a support group by combining an educational component with a chance for survivors to interact with each other.

"People do want to get together, and they want more information," said Messina Corder, cancer-program coordinator.

The Fredericksburg area is home to thousands of cancer survivors. Each year more than 1,000 people receive a cancer diagnosis, according to hospital figures. The number increases each year with the growing population.

For more information about the symposium, call 540/741-7765. To see more of The Free Lance-Star or to subscribe to the newspaper, go to http://fredericksburg.com/flshome. Copyright (c) 2009, The Free Lance-Star, Fredericksburg, Va. Distributed by McClatchy-Tribune Information Services. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.


Copyright (C) 2009, The Free Lance-Star, Fredericksburg, Va.

Disclaimer: References or links to other sites from Wellness.com does not constitute recommendation or endorsement by Wellness.com. We bear no responsibility for the content of websites other than Wellness.com.
Community Comments
Be the first to comment.